FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. There are described crystallised side-chain polymers which are applicable for various medical purposes. In specific applications, the heavy-atom crystallised side-chain polymers containing are especially applicable. An example of HACSCCP is a polymer which contains a main chain, a set of crystallised side chains and a set of heavy atoms attached to the polymer. In specific configurations, the heavy atoms are found in number which is effective to make the polymer X-ray contrast. A medical device may represent an embolotherapy system. A polymer material containing the SCC polymer is applicable for producing other medical devices, such as stents.
EFFECT: producing the polymer material containing HACSCCP which is applicable for producing the medical device designed for at least partial cavity closure.
26 cl, 1 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
POLYMERS WITH CRYSTALLISING SIDE CHAINS FOR MEDICAL USE | 2005 |
|
RU2383558C2 |
MULTI-PURPOSE BIORESORBABLE, INHERENTLY RADIO-OPAQUE POLYMERS | 2005 |
|
RU2396289C2 |
POLYMER, ESSENTIALLY RADIOPAQUE PRODUCTS FOR EMBOLIC THERAPY | 2004 |
|
RU2373958C2 |
STENT | 2007 |
|
RU2432183C9 |
N-SUBSTITUTED MONOMERS AND POLYMERS | 2007 |
|
RU2470040C2 |
CATHETER CYLINDER | 2011 |
|
RU2633723C2 |
LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR STIMULATORS | 2008 |
|
RU2510654C2 |
MIXTURE OF BUTYL IONOMERS | 2015 |
|
RU2700611C2 |
BIODECOMPOSING POLYMERS ABLE RECOVERY OF FORM | 1999 |
|
RU2215542C2 |
LOCAL VASCULAR DELIVERY OF PROBUCOL, ALONE OR IN COMBINATION WITH SIROLIMUS, FOR TREATMENT OF RESTENOSIS, VULNERABLE PLAQUES, AAA (ABDOMINAL AORTA ANEURISM) AND STROKE | 2008 |
|
RU2481084C2 |
Authors
Dates
2012-03-27—Published
2007-01-16—Filed